31 lines
2.0 KiB
JavaScript
31 lines
2.0 KiB
JavaScript
export default function OncologyIntro() {
|
|
return (
|
|
<section className="mx-auto px-10 pt-12">
|
|
<h1 className="text-4xl font-bold text-gray-700 text-left pb-2 mb-4">Oncology</h1>
|
|
<h2 className="text-2xl font-semibold text-gray-700 mb-4">Turning Complexity into Clarity</h2>
|
|
<p className="text-gray-600 leading-relaxed text-base mb-4 text-justify">
|
|
Cancer is not a single disease—it's a highly complex and dynamic group of disorders,
|
|
often driven by a multitude of genomic alterations. Despite advancements in treatment,
|
|
many patients still face uncertainty due to incomplete or delayed molecular diagnoses.
|
|
</p>
|
|
<p className="text-gray-600 leading-relaxed text-base mb-4 text-justify">
|
|
At Operify Health, we recognize that behind every tumor is a unique genetic story waiting
|
|
to be told. Our precision oncology solutions utilize high-throughput Next Generation
|
|
Sequencing (NGS) to analyze both somatic and germline mutations—providing clinicians
|
|
with actionable insights that inform targeted therapies, immunotherapy decisions, and
|
|
hereditary cancer risk assessments.
|
|
</p>
|
|
<p className="text-gray-600 leading-relaxed text-base mb-4 text-justify">
|
|
This genomic-driven approach is especially critical in advanced and treatment-resistant
|
|
cancers, where conventional methods often fall short. Studies have shown that integrating
|
|
broad-panel NGS into cancer care can impact clinical decision-making in up to 30% of cases,
|
|
leading to more personalized and effective treatment strategies.
|
|
</p>
|
|
<p className="text-gray-600 leading-relaxed text-base text-justify">
|
|
By combining cutting-edge sequencing, advanced bioinformatics, and curated clinical evidence,
|
|
Operify Health empowers oncologists to move from uncertainty to precision—ensuring every cancer
|
|
patient's care is as individualized as their diagnosis.
|
|
</p>
|
|
</section>
|
|
);
|
|
} |